United Orthopedic (4129) - Total Liabilities

Latest as of June 2026: NT$4.51 Billion TWD ≈ $141.96 Million USD

Based on the latest financial reports, United Orthopedic (4129) has total liabilities worth NT$4.51 Billion TWD (≈ $141.96 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore United Orthopedic (4129) long-term investment share to see how much of total assets are deployed in long-term investments.

United Orthopedic - Total Liabilities Trend (2015–2025)

This chart illustrates how United Orthopedic's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see total assets of United Orthopedic.

United Orthopedic Competitors by Total Liabilities

The table below lists competitors of United Orthopedic ranked by their total liabilities.

Company Country Total Liabilities
Sanstar Ltd
NSE:SANSTAR
India Rs1.09 Billion
Ioneer Ltd
AU:INR
Australia AU$3.24 Million
Hancom Inc
KQ:030520
Korea ₩210.22 Billion
Jeju Air Co Ltd
KO:089590
Korea ₩2.08 Trillion
Lionheart Holdings
NASDAQ:CUB
USA $10.11 Million
Dreamus Company
KQ:060570
Korea ₩72.58 Billion
Outbrain Inc
NASDAQ:OB
USA $317.87 Million
Funkwerk AG
F:FEW
Germany €70.25 Million

Liability Composition Analysis (2015–2025)

This chart breaks down United Orthopedic's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 4129 equity financing ratio to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.43 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 1.15 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.53 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how United Orthopedic's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for United Orthopedic (2015–2025)

The table below shows the annual total liabilities of United Orthopedic from 2015 to 2025.

Year Total Liabilities Change
2025-12-31 NT$3.62 Billion
≈ $113.98 Million
+17.10%
2024-12-31 NT$3.09 Billion
≈ $97.34 Million
+9.45%
2023-12-31 NT$2.82 Billion
≈ $88.93 Million
+11.77%
2022-12-31 NT$2.53 Billion
≈ $79.57 Million
+4.19%
2021-12-31 NT$2.42 Billion
≈ $76.38 Million
-8.94%
2020-12-31 NT$2.66 Billion
≈ $83.87 Million
+15.21%
2019-12-31 NT$2.31 Billion
≈ $72.80 Million
-11.11%
2018-12-31 NT$2.60 Billion
≈ $81.90 Million
+25.14%
2017-12-31 NT$2.08 Billion
≈ $65.45 Million
+79.97%
2016-12-31 NT$1.15 Billion
≈ $36.36 Million
+40.73%
2015-12-31 NT$820.18 Million
≈ $25.84 Million
--

About United Orthopedic

TWO:4129 Taiwan Medical Devices
Market Cap
$250.05 Million
NT$7.94 Billion TWD
Market Cap Rank
#15750 Global
#712 in Taiwan
Share Price
NT$82.30
Change (1 day)
-0.12%
52-Week Range
NT$81.20 - NT$131.00
All Time High
NT$131.00
About

United Orthopedic Corporation engages in the research, development, manufacture, and sale of orthopedic implants and surgical equipment in Taiwan, Asia, America, Europe, Africa, and Oceania. The company offers artificial hip joints, partial hip joints, joints for large trochanteric fractures, Moore hip prostheses, and customized artificial hip joints for individual tumor patients; artificial knee… Read more